Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2/3 1

Status

Terminated 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pathologic Complete Response 1

Interventions

Capecitabine 25 Oxaliplatin 24 Paclitaxel 23 Gemcitabine 21 Cisplatin 21 Fluorouracil 20 Carboplatin 18 Drug Therapy 17 Docetaxel 17 pembrolizumab 15 Leucovorin 15 Irinotecan 15 Radiotherapy 12 tislelizumab 11 Injections 10 Radiation 9 Pemetrexed 9 Magnetic Resonance Spectroscopy 9 Bevacizumab 9 toripalimab 8 Cetuximab 8 Surgical Procedures, Operative 7 Specimen Handling 7 Radiotherapy, Intensity-Modulated 7 Azacitidine 7 venetoclax 6 sintilimab 6 atezolizumab 6 Topotecan 6 Cyclophosphamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Not yet recruiting × tegafur-gimeracil-oteracil × Clear all

NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting

Pathologic Complete Response

Data powered by HemOnc (CC BY 4.0) Colophon ⚡